Finance

Lists
Why is TTRX up 3.98%?
Dive Deeper
TTRX:NASDAQ
Turn Therapeutics Inc
$8.89
+3.98%
(+0.34) 1D
Nov 18, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TTRX...
Open
$8.74
High
$9.43
Low
$8.19
Mkt. cap
271.79M
Avg. vol.
99.49K
Volume
52.42K
52-wk high
$16.45
52-wk low
$2.57
EPS
-$0.43
Shares outstanding
30.57M
No. of employees
2
Open
$8.74
High
$9.43
Low
$8.19
Mkt. cap
271.79M
Avg. vol.
99.49K
Volume
52.42K
52-wk high
$16.45
52-wk low
$2.57
EPS
-$0.43
Shares outstanding
30.57M
No. of employees
2
News stories
From web sources and news partners
About Turn Therapeutics Inc
CEO-
Employees2
Founded2015
HeadquartersWestlake Village, California, United States
SectorHealth Care
IndustryPharmaceutical industry
Analyst ratings
Based on 2 analysts giving stock ratings to TTRX in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for TTRX in the last 3 months.
Highest
Current $8.89
$24.00 (+169.97%)
Average
$17.00 (+91.23%)
Lowest
$10.00 (+12.49%)
Analyst
Recommendation
Action
Price target
Projected
Date
Karen Sterling
WBB Securities
Hold
Upgraded
$10.00
+12.5%
10/23/2026
Dev Prasad
Lucid Capital
Buy
Initiated
$24.00
+170%
09/24/2026
Unknown Analyst
WBB Securities
Sell
Downgraded
$10.00
+12.5%
09/14/2026
Rick Bienkowski
Ladenburg Thalmann & Co.
Buy
Maintained
$16.00
+80%
08/13/2026
Jason Kolbert
D. Boral Capital
Buy
Initiated
$8.00
-10%
12/29/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
496.95K
477.65K
638.75K
640.12K
Cost of revenue
496.95K
477.65K
638.75K
640.12K
Research and development expenses
34.93K
109.43K
475.06K
605.20K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.16M
1.14M
1.15M
1.38M
Operating expense
2.19M
1.25M
1.63M
1.98M
Total operating expenses
2.69M
1.72M
2.27M
2.62M
Operating income
-2.69M
-1.72M
-2.27M
-2.62M
Other non operating income
2.96M
703.14K
-3.34M
-3.35M
EBT including unusual items
279.07K
-970.97K
-5.85M
-6.23M
EBT excluding unusual items
279.07K
-970.97K
-5.85M
-6.23M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
279.07K
-970.97K
-5.85M
-6.23M
Net profit margin
-
-
-
-
Earnings per share
-
-0.04
-
-
Interest and investment income
14.18K
49.68K
-
83.97K
Interest expense
-
-
-241.36K
-341.21K
Net interest expenses
14.18K
49.68K
-241.36K
-257.24K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.68M
-1.71M
-2.25M
-2.61M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps